StockData
OKYO Pharma Ltd logo

OKYO Pharma Ltd (OKYO) stock

OKYONasdaqBiological Products, (No Diagnostic Substances)
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 20, 2026Score 1/30
$1.17−0.18 (-13.33%)

Close on Nov 16, 2026Market cap $61.40MP/E –Yield –

OKYO Pharma operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2026 it was -$5.94M. The highest annual figure on record is -$1.20M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Mar 31, 2026-$5.94M–
FY2025Mar 31, 2025-$1.81M–
FY2024Mar 31, 2024-$9.49M–
FY2023Mar 31, 2023-$7.70M–
FY2022Mar 31, 2022-$5.47M–
FY2021Mar 31, 2021-$1.60M–
FY2020Mar 31, 2020-$1.20M–

More OKYO Pharma figures

See a number that looks wrong?